Galectin-3 is not useful in thyroid FNA

被引:36
作者
Mills, LJ
Poller, DN [1 ]
Yiangou, C
机构
[1] Queen Alexandra Hosp, Dept Cytol, Portsmouth PO6 3LY, Hants, England
[2] Queen Alexandra Hosp, Dept Surg, Portsmouth PO6 3LY, Hants, England
关键词
thyroid FNA; cytology; galectin-3; negative staining; carcinoma;
D O I
10.1111/j.1365-2303.2005.00213.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Previous studies have suggested that galectin-3 immunohistochemistry may be useful in the fine needle aspiration (FNA) diagnosis of thyroid carcinoma as it has been reported to selectively stain carcinomas and not adenomas or goitres. Methods: Fifty-one patients were included in a prospective study of galectin-3 in thyroid FNA; 88.2% were female and 11.8% male, mean age 53 years, range 25-87 years. Cell blocks were prepared and stained for galectin- 3 if any cells were present in needle washings from the respective FNAs. Results: Twelve of 51 (23.5%) of cell blocks contained epithelial cells. One benign and one inadequate FNA were negative for galectin-3 staining. One of five non- diagnostic FNA cases, a papillary carcinoma on final histology showed positive staining. Four follicular neoplasm/ suspicious of carcinoma cases showed negative staining. One malignant FNA case, a papillary carcinoma showed positive staining with galectin- 3 but three further carcinomas, two papillary and one follicular were galectin- 3 negative. Conclusion: Galectin- 3 immunohistochemistry does not appear to be a useful adjunct to diagnosis in thyroid FNA as it does not reliably distinguish malignant and benign lesions. Many thyroid aspirates are of low cellularity and are not suitable for cell block immunohistochemistry.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 28 条
[1]   Increased galectin-3 expression in gastric cancer:: Correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation [J].
Baldus, SE ;
Zirbes, TK ;
Weingarten, M ;
Fromm, S ;
Glossmann, J ;
Hanisch, FG ;
Mönig, SP ;
Schröder, W ;
Flucke, U ;
Thiele, J ;
Hölscher, AH ;
Dienes, HP .
TUMOR BIOLOGY, 2000, 21 (05) :258-266
[2]  
BARONDES SH, 1994, J BIOL CHEM, V269, P20807
[3]   Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions [J].
Bartolazzi, A ;
Gasbarri, A ;
Papotti, M ;
Bussolati, G ;
Lucante, T ;
Khan, A ;
Inohara, H ;
Marandino, F ;
Orlandi, F ;
Nardi, F ;
Vecchione, A ;
Tecce, R ;
Larsson, O .
LANCET, 2001, 357 (9269) :1644-1650
[4]   Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules [J].
Beesley, MF ;
McLaren, KM .
HISTOPATHOLOGY, 2002, 41 (03) :236-243
[5]   Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1 [J].
Casey, MB ;
Lohse, CM ;
Lloyd, RV .
ENDOCRINE PATHOLOGY, 2003, 14 (01) :55-60
[6]  
Castronovo V, 1996, J PATHOL, V179, P43, DOI 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO
[7]  
2-N
[8]   Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia [J].
Coli, A ;
Bigotti, G ;
Zucchetti, F ;
Negro, F ;
Massi, G .
HISTOPATHOLOGY, 2002, 40 (01) :80-87
[9]  
Cvejic D, 1998, ANTICANCER RES, V18, P2637
[10]  
DAVIES R, 2003, CYTOPATHOLOGY, V14, P9